China Resources Jiangzhong Pharmaceutical Co.,Ltd
600750.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.54B
Close$
Share Statistics
| Market cap | $14.54 Billion |
|---|---|
| Enterprise Value | $14.53 Billion |
| Dividend Yield | $1.38 (6.03%) |
| Earnings per Share | $1.43 |
| Beta | -0.05 |
| Outstanding Shares | 630,929,983 |
Return
| Return on Equity | 22.12% |
|---|---|
| Return on Assets | 13.00% |
| Return on Invested Capital | 20.32% |
Valuation & Multiples
| P/E Ratio | 16.34 |
|---|---|
| PEG | -113.9 |
| Price to Sales | 3.81 |
| Price to Book Ratio | 3.27 |
| Enterprise Value to Revenue | 3.62 |
| Enterprise Value to EBIT | 14.39 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 22, 2026
EPS Estimate
$0.38
Average shareholder expectationRevenue Estimate
$909.38 M
Average shareholder expectationNext Earnings Call
Expected Date
October 24, 2026
EPS Estimate
$0.28
Average shareholder expectationRevenue Estimate
$785.37 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About China Resources Jiangzhong Pharmaceutical Co.,Ltd
4,352 employees
CEO: Yongqian Xu China Resources Jiangzhong Pharmaceutical Co.,Ltd functions as a prominent Chinese manufacturer of a wide array of pharmaceutical products for the domestic market. Its extensive product portfolio includes a variety of over-the-counter (O...